Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

ZyGEM Signs OEM Deal with Quanta Biosciences

Published: Monday, July 02, 2012
Last Updated: Monday, July 02, 2012
Bookmark and Share
Leverages ZyGEM's unique enzymatic technology to enhance and simplify RNA sample preparation for research applications.

ZyGEM Corp. Ltd. has announced that it has entered into an agreement with Quanta BioSciences to incorporate ZyGEM’s advanced enzymatic RNA extraction technology into Quanta’s leading reagents for quantitative PCR sold to customers worldwide.

The collaboration will enable Quanta to incorporate ZyGEM’s proprietary technology for the extraction of RNA from diverse samples into its best-in-class reagents for quantitative PCR, which are used to enable sophisticated applications for gene expression, pathogen detection and genetic analyses in diverse industries including pharmaceutical R&D, diagnostics, agribusiness and bio-defense.

“ZyGEM’s RNA extraction technology represents a significant advance in sample preparation for RNA-based testing and analysis, and we are pleased to partner with leading reagent producer Quanta BioSciences to expand its availability,” said Paul Kinnon, CEO of ZyGEM.

Kinnon continued, “This agreement reinforces our strategy of partnering with innovative companies to bring the advantages of our accurate, fast and simple RNA and DNA extraction technologies to researchers around the globe.”

ZyGEM’s enzymatic technology uses a single tube process to provide complete extraction of RNA, including smaller RNA molecules such as non-coding RNA and micro-RNA that are excluded by other extraction methods.

It delivers higher molecular weight RNA and more representative transcriptome profiles than other methods and is well suited for complete gene expression and non-coding RNA analyses.

The technology has been shown to produce consistent, linear yields of nuclear RNA, thereby ensuring 100% reproducible results.

“As a leader in the design and manufacture of advanced reagents for quantitative biology, we are delighted to offer ZyGEM’s unique RNA extraction technology to our growing customer base,” said Will Geist, Vice President of Sales and Business Development at Quanta BioSciences.

“In our testing, ZyGEM’s technology rapidly produced high quality RNA, and we believe our customers will welcome the opportunity to obtain these benefits in their own work,” said David Schuster, Director of R&D at Quanta BioSciences.

Further terms of the agreement were not disclosed.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ZyGEM Incorporates its DNA Extraction Technology into RUBICON’s Research and Diagnostic Products
The agreement makes ZyGEM’s DNA extraction kits available to researchers worldwide.
Friday, May 29, 2009
Zygem Strengthens its Worldwide Presence with new Distribution Agreements in Asia Pacific Markets
Company gains access to key markets in China and South Korea via new distribution agreements for its DNA extraction kits.
Tuesday, May 19, 2009
ZyGEM and New Zealand’s ESR Continue Collaboration to Expand forensicGEM™ Family of DNA Extraction Kits
The collaboration is leveraging the capabilities of these two New Zealand innovators to accelerate the development of additional forensicGEM™ kits for flexible DNA extraction.
Friday, May 02, 2008
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos